Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

151.01 +1.77 (+1.19%)
Official Closing Price Updated: 7:00 PM EDT, Jul 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,469,984
Open 149.69
Bid (Size) 151.50 (5)
Ask (Size) 152.00 (6)
Prev. Close 149.24
Today's Range 149.16 - 151.08
52wk Range 143.13 - 175.97
Shares Outstanding 2,628,679,824
Dividend Yield 3.15%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?
Johnson & Johnson has beaten earnings per share in more than 10 straight quarters. Will the trend continue in Q2? 
Via Benzinga
3 Safe Dividend Kings to Recession-Proof Your Portfolio
These safe dividend kings belong to an elite club of companies that have paid dividends for more than 50 years. 
Via InvestorPlace

Performance

YTD
-5.60%
-5.60%
1 Month
+3.47%
+3.47%
3 Month
+4.54%
+4.54%
6 Month
-5.92%
-5.92%
1 Year
-5.07%
-5.07%

More News

Read More
Johnson & Johnson: Bullish Charts Signal Strong Setup Before Q2 Earnings
Via Benzinga
How To Earn $500 A Month From Johnson & Johnson Stock Ahead Of Q2 Earnings
Via Benzinga
If You Can Only Buy One Dow Stock in July, It Better Be One of These 3 Names
Via InvestorPlace
Topics Stocks
Exposures US Equities
Smart Money Is Betting Big In JNJ Options
Via Benzinga
NYSE:JNJ: good value for what you're paying.
Via Chartmill
Looking At Johnson & Johnson's Recent Unusual Options Activity
Via Benzinga
Dow Closes At New High As Q2 Earnings Season Heats Up
Via Talk Markets
Topics Stocks
Exposures US Equities
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
NKGen Biotech Appoints Dr. Marco Gottardis to its Board of Directors
From NKGen Biotech
Via GlobeNewswire
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
Via The Motley Fool
Netflix, Goldman Sachs, J&J, ASML Lead Q2 Reports This Week As Analysts See Earnings Growth Accelerating To Fastest In Over 2 Years
Via Benzinga
2 Healthcare Stocks to Buy Hand Over Fist This Month
Via The Motley Fool
3 High-Yield Dividend Stocks That Still Look Like Bargains
Via The Motley Fool
MarketBeat Week in Review – 7/8 - 7/12
Via MarketBeat
Topics Economy Stocks
Exposures Interest Rates US Equities
3 Key Earnings Reports To Watch Next Week
Via Talk Markets
3 Essential Stocks for Building a Recession-Proof Portfolio
Via InvestorPlace
Johnson & Johnson Strengthens Pipeline to Lead in Atopic Dermatitis With the Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26
From Johnson & Johnson
Via Business Wire
3 Magnificent Dow Stocks That Are No-Brainer Buys for the Second Half of 2024
Via The Motley Fool
Topics Stocks
Exposures US Equities
3 Undervalued Stocks Set to Outperform the Market in 2024
Via InvestorPlace
Johnson & Johnson Faces MedTech Challenges But Is 'On Track' To Meet 2024 Guidance: Goldman Sachs
Via Benzinga
Emergent BioSolutions And Johnson & Johnson Resolve Claims Over COVID-19 Vaccine Manufacturing
Via Benzinga
Exposures COVID-19
7 Diversified Income Powerhouses for Lifelong Cash Flow
Via InvestorPlace
3 Rock-Solid Income Machines to Hold for Decades
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.